Changes of biochemical bone markers during the menopausal transition

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 2, 2002, Pages 143-151

  Rosenbrock, Hilkea ^a   Seifert Klauss, Vanadin ^a   Kaspar, Susanne ^a   Busch, Raymonde ^a   Luppa, Peter B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biochemical bone markers; Bone mineral density; Menopausal transition

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; ESTROGEN; OSTEOCALCIN; PYRIDINIUM DERIVATIVE; PYRIDINOLINE; SIALOPROTEIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CARBOXY TERMINAL SEQUENCE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORRELATION FUNCTION; CROSS LINKING; FEMALE; HUMAN; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0036210087     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.025     Document Type: Article

References (39)

1. Biochemical markers of bone turnover. Applications for osteoporosis
2. Bone turnover markers and 17b-estradiol level in postmenopausal women
3. Perimenopause: The complex endocrinology of the menopausal transition
4. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis
5. New markers of bone metabolism: Clinical use in metabolic bone disease
6. Molecular basis and clinical application of biological markers of bone turnover
7. Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients?
8. The performance and utility of biochemical markers of bone turnover: Do we know enough to use them in clinical practice?
9. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric asssay
10. Biological variability in assessing the clinical value of biochemical markers of bone turnover
11. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases
12. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women
13. Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years
14. The effect of menopause on biochemical markers and ultrasound densitometry in healthy females
15. Metabolic markers for the early diagnosis of postmenopausal osteoporosis
16. Influence of sex and age on biochemical bone metabolism parameters
17. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen
18. Biochemical markers of bone turnover during hormone replacement therapy
19. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early post-menopausal women
20. Monitoring individual response to hormone replacement therapy with bone markers
21. The European spine phantom - A tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT
22. On closed testing procedures with special reference to ordered analysis of variance
23. The endocrinology of the menopause
24. Biochemical markers as predictors of rates of bone loss after menopause
25. Bone sialoprotein in serum of patients with malignant bone diseases
26. Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerized Asp-Gly sequence within the C-terminal telopeptide (α1) region
27. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers
28. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis
29. Changes in levels of biochemical markers and ultrasound indices of Os calcis across the menopausal transition
30. Bone metabolism during the perimenopausal transition: A prospective study
31. Bone turnover markers and bone density across the menopausal transition
32. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women
33. Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women
34. Monitoring of bone turnover. Biological, pre-analytical and technical criteria in the assessment of biochemical markers
35. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability
36. Variability and response of urinary resorption markers to hormone replacement therapy
37. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
38. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trail
39. Interlaboratory variation of biochemical markers of bone turnover